Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in Host Response to Mycobacterium tuberculosis Infection Associated With Type 2 Diabetes: Beyond Hyperglycemia
Cristian Alfredo Segura-Cerda, Wendy López-Romero, Mario Alberto Flores‐Valdez
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment
Anna Allué‐Guardia, Juan Ignacio García, Jordi B. Torrelles
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 168
Green Synthesis of Copper Oxide Nanoparticles Using Sesbania grandiflora Leaf Extract and Their Evaluation of Anti-Diabetic, Cytotoxic, Anti-Microbial, and Anti-Inflammatory Properties in an In-Vitro Approach
Kanagavalli Ramasubbu, S. Anantha Padmanabhan, Khalid A. Al‐Ghanim, et al.
Fermentation (2023) Vol. 9, Iss. 4, pp. 332-332
Open Access | Times Cited: 45
Tuberculosis and diabetes mellitus: The complexity of the comorbid interactions
Augustine Asare Boadu, Michelle Yeboah-Manu, Stephen Osei-Wusu, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107140-107140
Closed Access | Times Cited: 14
Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
Anna Allué‐Guardia, Rajagopalan Saranathan, John Chan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 735-735
Open Access | Times Cited: 44
Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
Chin‐Hsiao Tseng
Journal of Clinical Medicine (2018) Vol. 7, Iss. 9, pp. 264-264
Open Access | Times Cited: 59
Tuberculosis endotypes to guide stratified host-directed therapy
Andrew R. DiNardo, Tomoki Nishiguchi, Sandra L. Grimm, et al.
Med (2021) Vol. 2, Iss. 3, pp. 217-232
Open Access | Times Cited: 29
Mycobacteriophages: therapeutic approach for mycobacterial infections
Sunil Kumar Raman, D.V. Siva Reddy, Vikas Jain, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104049-104049
Closed Access | Times Cited: 4
Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities
Alba Llibre, Martin Dedicoat, Julie G. Burel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Host Metabolic Changes during Mycobacterium Tuberculosis Infection Cause Insulin Resistance in Adult Mice
Neelam Oswal, Kezia Lizardo, Dhanya Dhanyalayam, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1646-1646
Open Access | Times Cited: 19
BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
Kee Woong Kwon, Michel de Jesús Aceves-Sánchez, Cristian Alfredo Segura-Cerda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients
Jichan Shi, Guiqing He, Hongye Ning, et al.
Tuberculosis (2022) Vol. 135, pp. 102209-102209
Open Access | Times Cited: 17
Phage Therapy for Mycobacteria: Overcoming Challenges, Unleashing Potential
Christoffel J. Opperman, Adrian Brink
Infectious Disease Reports (2025) Vol. 17, Iss. 2, pp. 24-24
Open Access
Subtractive Genomics for Identifying Tuberculosis-Linked Bacterial Targets in Type-2 Diabetes and Drug Repurposing Strategies
Md. Kaderi Kibria, Jannatul Nayem Fariha, Most. Nusrat Jahan Resma, et al.
Next research. (2025), pp. 100377-100377
Closed Access
Screening for pulmonary tuberculosis in high-risk groups of diabetic patients
Ye Ji, Hengfu Cao, Qiao Liu, et al.
International Journal of Infectious Diseases (2020) Vol. 93, pp. 84-89
Open Access | Times Cited: 25
Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization
Chidchamai Kewcharoenwong, Satria A. Prabowo, Gregory J. Bancroft, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 25
Independent effect of weather, air pollutants, and seasonal influenza on risk of tuberculosis hospitalization: An analysis of 22-year hospital admission data
Ka Chun Chong, Eng‐Kiong Yeoh, Chi Chiu Leung, et al.
The Science of The Total Environment (2022) Vol. 837, pp. 155711-155711
Closed Access | Times Cited: 12
Drug resistance in Mycobacterium tuberculosis: an evolutionary perspective and its adaptation to the lung microenvironment
Satyendra N. Shukla, Nitin Bhardwaj, Ashutosh Singh
The Microbe (2024) Vol. 5, pp. 100189-100189
Open Access | Times Cited: 2
BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines
Cristian Alfredo Segura-Cerda, Brenda Marquina‐Castillo, Vasti Lozano-Ordaz, et al.
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 17
Effect of Immunomodulating Extract and Some Isolates from Etlingera rubroloba A.D. Poulsen Fruits on Diabetic Patients with Tuberculosis
Muhammad Ilyas Yusuf, Idin Sahidin, Asriullah Jabbar, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2401-2401
Open Access | Times Cited: 6
Metabolic changes enhance necroptosis of type 2 diabetes mellitus mice infected with Mycobacterium tuberculosis
Abhinav Vankayalapati, Olamipejo Durojaye, Tanmoy Mukherjee, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 5, pp. e1012148-e1012148
Open Access | Times Cited: 2
Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone
George A. Yendewa, Sulaiman Lakoh, Darlinda F. Jiba, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3466-3466
Open Access | Times Cited: 10
Subjects With Diabetes Mellitus Are at Increased Risk for Developing Tuberculosis: A Cohort Study in an Inner-City District of Barcelona (Spain)
Violeta Antonio-Arques, Josep Franch‐Nadal, Antonio Moreno-Martínez, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 9
Phages for the treatment of Mycobacterium species
Christoffel J. Opperman, Justyna Wojno, Wynand J. Goosen, et al.
Progress in molecular biology and translational science (2023), pp. 41-92
Closed Access | Times Cited: 4
Prediabetes and the treatment outcome of tuberculosis: A meta‐analysis
Lingbo Liang, Qiaoli Su
Tropical Medicine & International Health (2024) Vol. 29, Iss. 9, pp. 757-767
Closed Access | Times Cited: 1
Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection
Chidchamai Kewcharoenwong, Wipawee Saenwongsa, Sam Willcocks, et al.
Tuberculosis (2020) Vol. 123, pp. 101939-101939
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top